Hepatitis C virus infection and kidney transplantation: Predictors of patient and graft survival

Transplantation

Volumn 83, Issue 7, 2007, Pages 853-857

  Maluf, Daniel G ^a,c   Fisher, Robert A ^a   King, Anne L ^a   Gibney, Eric M ^a   Mas, Valeria R ^a,b   Cotterell, Adrian H ^a   Shiffman, Mitchell L ^a   Sterling, Richard K ^a   Behnke, Martha ^a   Posner, Marc P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Hepatitis C virus infection; Kidney transplantation; Posttransplant outcomes

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; UNIVARIATE ANALYSIS;

BIOPSY; CADAVER; FEMALE; FISH OILS; GRAFT SURVIVAL; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER; LIVING DONORS; MALE; MIDDLE AGED; TISSUE DONORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 34247578041     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000259725.96694.0a     Document Type: Article

References (37)

1. Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51: 981.
2. Tokars J, Alter MJ, Favero MS, et al. National surveillance of hemodialysis associated diseases in the United States, 1992. ASAIO J 1994; 40: 1020.
3. Pereira BJG, Wright TL, Schmid CH, et al. The Impact of Pretransplantation Hepatitis C. Infection on the Outcome of Renal Transplantation. Transplantation 1995; 60: 799.
4. Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C - Its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273.
5. Huang C-C, Liaw Y-F, Lai M-K, et al. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992; 53: 763.
6. Ponz E, Campistol JM, Barrera JM, et al. Hepatitis C virus antibodies in patients on hemodialysis and after transplantation. Transplant Proc 1991; 23: 1371.
7. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238.
8. Roth D. Hepatitis C virus: The nephrologist's view. Am J Kidney Dis 1995; 25: 3.
9. Ynares C, Johnson HK, Kerlin T, et al. Impact of pretransplant hepatitis Cantibody status upon long-term patient and renal allograft survival-A 5- and 10-year follow-up. Transplant Proc 1993; 25: 1466.
10. Fritsche C, Brandes JC, Delaney SR, et al. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation 1993; 55: 1283.
11. Port F, Wolfe R, Mauger E, et al. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993; 270: 1339.
12. Parfrey PS, Forbes RDC, Hutchinson TA, et al. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1985; 39: 610.
13. Rubin RH, Tolkoff-Rubin NE. Infection: The new problems. Transplant Proc 1989; 21: 1440.
14. Wells JT, Lucey MR, Said A. HepatitisCin transplant recipients of solid organs, other than livers. Clin Liver Dis 2006; 10: 901.
15. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431.
16. Abbott KC, Bucci JR, Matsumoto CS. Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 2003; 14: 2908.
17. Bucci JR, Matsumoto CS, Swanson SJ. Donor hepatitis C seropositivity Clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation. J Am Soc Nephrol 2002; 13: 2974.
18. Batty Jr DS, Swanson SJ, Kirk AD. Hepatitis C virus seropositivity at the time of renal transplantation in the United States Associated factors and patient survival. Am J Transplant 2001; 1: 179.
19. Legendre C, Garrigue V, Le Bihan C. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667.
20. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Aljama P. Risk of death and liver cirrhosis in anti-HCV-positive long term haemodialysis patients. Nephol Dial Transplant 2001; 16: 1669.
21. Knoll GA, Tankersley MR, Lee JY, et al. The impact of renal transplantation on survival in hepatitis C positive end-stage renal disease patients. Am J Kidney Dis 1997; 29: 608.
22. Pereira BJ, Natov SN, Bouthot BA, et al. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998; 53: 1374.
23. Roth D, Zucker K, Cirocco R, et al. A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation 1996; 61: 886.
24. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplant outcome. Hepatology 1999; 29: 257.
25. Rao KV, Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 1996; 62: 1765.
26. Yilmaz N, Shiffman ML, Stravitz RT, et al. Fibrosis progression and graft loss in patients with recurrent HCV following liver transplantation. Abstract #1641. Boston: American Transplantation Congress; 2005.
27. Pedroso S, Martins L, Fonseca I, et al. Impact of hepatitis C virus on renal transplantation: association with poor survival. Transplant Proc 2006; 38: 1890.
28. Kimball P, Verbeke S, Shiffman M. HCV core protein augments cyclosporine immunosuppression. Transplant Proc 2005; 37: 652.
29. Yao ZQ, Ray S, Eisen-Vandervelde A, et al. Hepatitis C virus: immunosuppression by complement regulatory pathway. Viral Immunol 2001; 14: 277.
30. Sterling RK, Sanyal AJ, Luketic VA, et al. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999; 12: 3576.
31. Rao KV, Anderson WR, Kasiske BL, Dahl DC. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993; 94: 241.
32. Wolfe AR, Ashby BV, Milford EL, et al. Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant. N Engl J Med 1999; 341: 1725.
33. Bleyer AJ, Tell GS, Evans GW, et al. Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences. Am J Kidney Dis 1996; 28: 72.
34. Crook ED, Penumalee S, Gavini B, Filippova K. Hepatitis C is a predictor of poorer renal survival in diabetic patients. Diabetes Care 2005; 28: 2187.
35. Foster CE 3rd, Philosophe B, Schweitzer EJ, et al. A decade of experience with renal transplantation in African-Americans. Ann Surg 2002; 236: 794.
36. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32: 629.
37. Koyama H, Cecka JM, Terasaki PI. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival. Transplantation 1994; 57: 1064.